In Silico modulation of apoptotic bcl-2 proteins by mistletoe lectin-1: Functional consequences of protein modifications

Journal of Cellular Biochemistry

Volumn 103, Issue 2, 2008, Pages 479-491

  Khwaja, Tasneem A ^a,b   Wajahat, Tayyaba ^a   Ahmad, Ishtiaq ^a   Hoessli, Daniel C ^c   Walker Nasir, Evelyne ^a   Kaleem, Afshan ^a   Qazi, Wajahat M ^a   Shakoori, Abdul R ^d   Nasir ud Din, ^a,e  

^a Institute of Molecular Sciences and Bioinformatics Lahore   (Pakistan)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d UNIVERSITY OF THE PUNJAB   (Pakistan)

^e UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Apoptosis; Glycosylation; Multifunctional protein; Phosphorylation; Posttranslational modifications; Yin Yang sites

Indexed keywords

N ACETYLGLUCOSAMINE; PROTEIN BCL 2; SERINE; THREONINE; TRANSCRIPTION FACTOR YY1; VISCUM ALBUM LECTIN;

APOPTOSIS; ARTICLE; BINDING SITE; COMPLEX FORMATION; COMPUTER MODEL; DEPHOSPHORYLATION; GLYCOSYLATION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; CATS; CATTLE; CONSERVED SEQUENCE; CRICETINAE; CRICETULUS; DEER; DOGS; GLYCOSYLATION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PLANT PREPARATIONS; PLANT PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; RIBOSOME INACTIVATING PROTEINS, TYPE 2; SEQUENCE ALIGNMENT; SHEEP; SPECIES SPECIFICITY; TOXINS, BIOLOGICAL;

EID: 38649117279     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21412     Document Type: Article

References (44)

1. Adams JM, Cory S. 2001. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26:61-66.
2. Ahmad I, Hoessli DC, Walker-Nasir E, Rank SM, Shakoori AR, Nasir-ud-Din. 2006. Oct-2 DNA binding transcription factor: Functional consequences of Phosphorylation and glycosylation. Nucleic Acids Res 34:175-184.
3. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402.
4. Attwood T. 2000. The quest to deduce protein function from sequence: The role of pattern databases Int. J Biochem Cell Biol 32:139-155.
5. Bantel H, Engels IH, Voelter W, Schulze-Osthoff K, Wesselborg S. 1999. Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis. Cancer Res 59:2083-2090.
6. Barsyte-Lovejoy D, Galanis A, Sharrocks AD. 2002. Specificity determinants in MAPK signaling to transcription factors. J Biol Chem 277:9896-9903.
7. Blom N, Gammeltoft S, Brunak S. 1999. Sequence- and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294:1351-1356.
8. Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O'Donovan C, Phan I, Pilbout S, Schneider M. 2003. The Swiss-Prot protein knowledge base and its supplement TrEMBL in. 2003. 31:365-370.
9. Boneberg EM, Hartung T. 2001. Mistletoe Lectin-1 increases tumor necrosis factor-alpha release in lipopolysaccharide-stimulated whole blood via inhibition of interleukin-10 production. J Pharmacol 298:996-1000.
10. Bork P, Dansekar T, Diaz-Lazcoz Y, Eisenhaber F, Huynen M, Yuan Y. 1998. Predicting function: From genes to genome and back. J Mol Biol 283:707-725.
11. Breitschopf K, Haendeler J, Malchow P, Andreas M, Zeiher AM, Dimmeler S. 2000. Post-translational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathway. Mol Cell Biol 20:1886-1896.
12. Bruseth S, Enge A. 1990. Mistletoe in the treatment of cancer. Tidsskr Nor Laegeforen 13:1058-1060.
13. Bussing A, Suzart K, Bergmann J, Pfuller U, Schietzel M, Schweizer K. 1996. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectin. Cancer Lett 99:59-72.
14. Cartron PF, Oliver L, Juin P, Meflah K, Valletta FM. 2004. The p18 truncated form of Bax behaves like a Bcl-2 homology domain 3-only protein. J Biol Chem 279: 11503-11512.
15. Christlet THT, Veluraja K. 2001. Database analysis of O-glycosylation sites in proteins. Biophys J 80:952-960.
16. Croce LD. 2005. Chromatin modifying activity of leukaemia associated fusion proteins. Hum Mol Genet 14:R77-R84.
17. Deng X, Gao F, Flagg T, May WS Jr. 2004. Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions. Proc Natl Acad Sci 101:153-158.
18. Dharap SS, Wang Y, Chandna P, Khandare JJ, Qiu B, Gunaseelan S, Sinko PJ, Stein S, Farmanfarmaian A, Minko T. 2005. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. PNAS 102: 12962-12967.
19. Eisenmann KM, VanBrocklin MW, Staffend NA, Kitchen SM, Koo HM. 2003. Mitogen-activated protein kinase pathway-dependent tumor-specific survival signaling in melanoma cells through inactivation of the proapoptotic protein Bad. Cancer Res 63:8330-8337.
20. Franz H. 1986. Mistletoe lectins and their A and B chains. Oncology 43:23-34.
21. Franz H, Ziska P, Kindt A. 1981. Isolation and properties of three lectins from mistletoe (Viscum album L). Biochem J 195:481-484.
22. Gardai SJ, Hildeman DA, Frankel SK, Whitlock BS, Frasch SC, Borregaard N, Marrack P, Bratton DL, Henson PM. 2004. Phosphorylation of Bax Ser 184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 279: 21085-21095.
23. Griffith LS, Schmitz B. 1999. O-linked N-acetylglucosamine levels in cerebellar neurons respond reciprocally to perturbations of phosphorylation. Eur J Biochem 262: 824-831.
24. Heiny BM, Beuth J. 1994. Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients. Anticancer Res 14:1339-1342.
25. Kearse KP, Hart GW. 1991. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc Natl Acad Sci 88:1701-1705.
26. Khwaja TA, Dias CB, Pentecost S. 1986. Recent studies on the anticancer activity of mistletoe (Viscum album) and its alkaloids. Oncology 43:42-50.
27. Kolch W, Mischak H, Pitt AR. 2005. The molecular make-up of a tumour: Proteomics in cancer research. Clin Sci 108:369-383.
28. Kovacs E. 2002. The in vitro effect of Viscum album (VA) extract on DNA repair of peripheral blood mononuclear cells (PBMC) in cancer patients. Phytother Res 16:143-147.
29. Krueger KE, Srivastava S. 2006. Posttranslational protein modifications: Current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteome 5:1799-1810.
30. Lyu SY, Choi SH, Park WB. 2002. Korean mistletoe lectin-induced apoptosis in hepato-carcinoma cells is associated with inhibition of telomerase via mitochondrial controlled pathway independent of p53. Arch Pharm Res 25:93-101.
31. Niwa H, Tonevitsky AG, Agapov II, Saward S, Pfuller U, Palmer RA. 2003. Crystal structure at 3 A of mistletoe lectin I, a dimeric type-II ribosome-inactivating protein, complexed with galactose. Eur J Biochem 270:2739-2749.
32. Pae Ho, Seo WG, Oh GS, Shin MK, Lee HS, Kim SB, Chung HT, 2000. Potentiation of tumor necrosis factor-alpha-induced apoptosis by mistletoe lectin. Immunopharmacol Immunotoxicol 22:697-709.
33. Putcha GV, Deshmukh M, Johnson EM Jr. 1999. BAX Translocation is a critical event in neuronal apoptosis: Regulation by neuroprotectants, Bcl-2, and caspases. J Neurosci 19:7476-7485.
34. Qazi WM, Ahmed M, Hoessli DC, Ahmad I, Khawaja I, Wajahat T, Kaleem A, Walker-Nasir E, Rahman N, Shakoori AR, Nasir-ud-din. 2006. Consensus sequences as targets for phosphorylation of amino acids in phosphoproteins: Statistical computing analysis. Pakistan J Zool 38:55-63.
35. Ruvolo PP, Deng X, May WS. 2001. Phosphorylation of Bcl-2 and regulation of apoptosis. Leukemia 15:515-522.
36. Sunayama J, Tsuruta F, Masuyama N, Gotoh Y. 2005. JNK antagonizes Akt-mediated survival signals by phosphorylating 14- 3-3. J Cell Biol 170:295-304.
37. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTALW: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673-4680.
38. Tomonaga T, Matsushita K, Yamaguchi S, Oh-Ishi M, Kodera Y, Maeda T, Hideaki Shimada, Ochiai T, Nomura F. 2004. Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis. Clin Cancer Res 10:2007-2014.
39. Valladares A, Alvarez AM, Ventura JJ, Roncero C, Benito M, Porras A. 2000. P38 mitogen-activated protein kinase mediates tumor necrosis factor-alpha induced apoptosis in rat fetal brown adipocytes. Endocrinology 141:4383-4395.
40. Van Cruchten S, Van Den Broeck W. 2002. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Anat Histol Embryol 31:214-223.
41. Verma S, Zhao L-J, Chinnadurai G. 2001. Phosphorylation of the pro-apoptotic protein BIK. J Biol Chem 276:4671-4676.
42. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. 1995. Bad, a heterodimeric partner for Bcl-XL and Bcl-2 displaces Bax and promotes cell death. Cell 80:285-291.
43. Zachara NE, Hart GW. 2002. The emerging significance of O-GlcNAc in cellular regulation. Chem Rev 102:431-438.
44. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. 1996. Ser phosphorylation of death agonist BAD in response to survival factor results in binding to 14- 3-3not BCL-X (L). Cell 87:619-628.